4.5 Article

Course of psychiatric comorbidity and utilization of mental health care after laryngeal cancer: a prospective cohort study

Journal

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
Volume 274, Issue 3, Pages 1591-1599

Publisher

SPRINGER
DOI: 10.1007/s00405-016-4340-7

Keywords

Head and neck cancer; Transoral surgery; Mental health care; Oncology; Psychosocial care needs; Mental disorders

Funding

  1. German Cancer Aid [107440, 109604]

Ask authors/readers for more resources

In a German multi-center prospective cohort study, we wanted to assess the course of psychiatric comorbidity, utilization of mental health care and psychosocial care needs in laryngeal cancer patients during the first year after partial laryngectomy (PRL). Structured interviews with patients were conducted before surgery, 1 week (1 w), 3 months (3 m) and 1 year (12 m) after PRL. Psychiatric comorbidity was assessed using the Structured Clinical Interview for DSM-IV (SCID). Psychosocial care needs and utilization of mental health care were evaluated with standardized face-to-face interviews. In 176 patients, psychiatric disorders were prevalent in 11 % (1 w), 15 % (3 m) and 14 % (12 m), respectively, of which 4 % (12 m) underwent psychiatric treatment or psychotherapy. Two percent had acute, 15 % emerging and 6 % chronic psychiatric comorbidity. Chronically mental ill patients were more frequently younger than 65 years (p = 0.026), female (p = 0.045) and experienced more often a need for psychological counseling (p <= 0.001). One year after surgery, 27 % of the comorbid psychiatric patients expressed a need for additional psychological counseling. Alcohol-related disorders were diagnosed in 3 % (1 w), 3 % (3 m) and 8 % (12 m), respectively. Only one of these patients received psychological treatment, while 14 % expressed a need for psychological counseling and 7 % for additional medical consultations. The non-treatment of alcohol-related disorders measured in our sample indicates a major problem since continued alcohol consumption in laryngeal cancer patients is associated with reduced global quality of life, increased functional impairments and reduced overall survival. Screening instruments integrated into acute care are necessary to detect harmful drinking behavior.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Medicine, Research & Experimental

Management of Older Patients with Head and Neck Cancer: A Comprehensive Review

Leandro L. Matos, Alvaro Sanabria, K. Thomas Robbins, Gyorgy B. Halmos, Primoz Strojan, Wai Tong Ng, Robert P. Takes, Peter Angelos, Cesare Piazza, Remco de Bree, Ohad Ronen, Orlando Guntinas-Lichius, Avraham Eisbruch, Mark Zafereo, Antti A. Makitie, Ashok R. Shaha, Andres Coca-Pelaz, Alessandra Rinaldo, Nabil F. Saba, Oded Cohen, Fernando Lopez, Juan P. Rodrigo, Carl E. Silver, Timo E. Strandberg, Luiz Paulo Kowalski, Alfio Ferlito

Summary: The projected increase in life expectancy is expected to lead to a rise in age-related diseases, including cancer. This report critically reviews the literature on managing older patients with head and neck cancer (HNC). Older adults, especially those who are frail or have comorbidities, are more prone to complications and toxicities from HNC treatment. Screening older patients for predispositions and managing comorbidities is essential. Age alone should not be a determining factor for less intensive treatment, and older patients should be treated according to the best standard of care to avoid increased treatment failure rates and mortality. A multidisciplinary tumor board should establish the treatment plan, involving shared decision-making with patients and family, and treatment modifications should be considered for patients with severe comorbidities, frailty, or who refuse recommendations.

ADVANCES IN THERAPY (2023)

Article Otorhinolaryngology

Effect of simulated acute bilateral severe conductive hearing loss on static balance function in healthy subjects: a prospective observational pilot study

Johanna Westermann-Lammers, Jawad Salameh, Christian Dobel, Orlando Guntinas-Lichius

Summary: A pilot study was conducted on 25 normal hearing young adults to investigate the effect of simulated acute hearing loss on static balance function. The study found that simulated moderate to severe bilateral conductive hearing loss did not disturb the static balance function in normal hearing younger adults.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2023)

Article Otorhinolaryngology

Position paper: ICD coding of chronic rhinosinusitis with nasal polyps (CRSwNP) in the ICD-10-GM as a basis for therapy with biologics

S. Becker, M. Laudien, U. Foerster-Ruhrmann, H. Olze, C. Rudack, A. M. Chaker, J. Hagemann, T. Huppertz, T. K. Hoffmann, S. Dazert, T. Deitmer, S. Strieth, H. Wrede, W. Schlenter, H. J. Welkoborsky, B. Wollenberg, F. Baerhold, F. Klimek, R. Kianfar, J. Zuberbier, M. Cuevas, C. A. Hintschich, O. Guntinas-Lichius, T. Stoever, C. Bergmann, P. Werminghaus, O. M. Groeger, C. Beutner, R. K. Weber, T. Hildenbrand, A. S. Hoffmann, L. Klimek

LARYNGO-RHINO-OTOLOGIE (2023)

Article Otorhinolaryngology

Radiation or Surgery for HPV-positive oropharyngeal cancer? The ORATOR2 Trial - Comparing apples and oranges

H. B. Zech, C. S. Betz, T. K. Hoffmann, J. P. Klussmann, T. Deitmer, O. Guntinas-Lichius

Summary: The ORATOR2 trial investigated therapy de-escalation in early human papillomavirus (HPV)-related oropharyngeal squamous cell carcinomas (OPSCC). The study compared radiotherapy with trans-oral surgery and neck dissection in 61 patients. The primary endpoint favored radiotherapy, but the trial had limitations and caution should be exercised in drawing conclusions for clinical practice.

LARYNGO-RHINO-OTOLOGIE (2023)

Article Otorhinolaryngology

Recommendations for reviewing the effectiveness and documentation of the course of mepolizumab in chronic rhinosinusitis with nasal polyps (CRSwNP) in the German healthcare system

L. Klimek, U. Foerster-Ruhrmann, H. Olze, A. G. Beule, A. M. Chaker, J. Hagemann, T. Huppertz, T. K. Hoffmann, S. Dazert, T. Deitmer, S. Strieth, H. Wrede, W. Schlenter, H. J. Welkoborsky, B. Wollenberg, S. Becker, F. Baerhold, F. Klimek, I. Casper, J. Zuberbier, C. Rudack, M. Cuevas, C. A. Hintschich, O. Guntinas-Lichius, T. Stoever, C. Bergmann, P. Werminghaus, O. Pfaar, J. Gosepath, M. Groeger, C. Beutner, M. Laudien, R. K. Weber, T. Hildenbrand, A. S. Hoffmann, C. Bachert

Summary: This study analyzed previous data on the treatment of CRSwNP with mepolizumab and provided recommendations for follow-up, therapy intervals, possible therapy pauses, and discontinuation of therapy when using mepolizumab as add-on therapy for severe CRSwNP.

LARYNGO-RHINO-OTOLOGIE (2023)

Article Otorhinolaryngology

On the state of intersectoral treatment in otolaryngology in Germany-Results of a survey

H-J Welkoborsky, Thomas Deitmer, Jan Loehler, Orlando Guntinas-Lichius

Summary: The German Healthcare System is undergoing significant changes and requires appropriate intersectoral treatment structures. ENT department chairmen and ENT specialists in private practice believe that the current remuneration system needs urgent revision. Challenges include emergency care, information transfer for inpatients, and problems with continuing education of residents.

LARYNGO-RHINO-OTOLOGIE (2023)

Editorial Material Otorhinolaryngology

Recommendations of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC) for the granting of resident training program authorizations

Orlando Guntinas-Lichius, Stephan Lang, Timo Stoever, Thomas K. Hoffmann, Stefan Plontke, Hans-Juergen Welkoborsky, Thomas Zahnert, Burkard M. Lippert, Nicole Rotter, S. Dazert, Andreas Dietz, Thomas Deitmer

Summary: The 2018 template for otorhinolaryngology specialist training in Germany is being implemented by the federal associations. The German Society and Professional Association of German Otorhinolaryngologists recommended a training plan for Otorhinolaryngology, Head and Neck Surgery as a guideline for the federal medical associations. The state medical associations are currently working on criteria for granting authority to otorhinolaryngologists and training institutions.

LARYNGO-RHINO-OTOLOGIE (2023)

Article Oncology

The Association between Patient's Age and Head and Neck Cancer Treatment Decision-A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany

Mussab Kouka, Isabel Hermanns, Peter Schlattmann, Orlando Guntinas-Lichius

Summary: This population-based study in Germany found that the patient's age plays an important role in the treatment decision for head and neck cancer. Older patients are more likely to undergo surgery, radiotherapy, and chemotherapy.

CANCERS (2023)

Article Oncology

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial

Susanne Wiegand, Gunnar Wichmann, Jeannette Vogt, Kathrin Vogel, Annegret Franke, Thomas Kuhnt, Florian Lordick, Anne-Marie Scheuble, Peter Hambsch, Peter Brossart, Franz Georg Bauernfeind, Holger Kaftan, Georg Maschmeyer, Matthias Paland, Marc Muenter, Victor Lewitzki, Nicole Rotter, Carmen Stromberger, Marcus Beck, Steffen Dommerich, Thomas Christoph Gauler, Gunnar Hapke, Orlando Guntinas-Lichius, Ursula Schroeder, Martin Goerner, Matthias G. Hautmann, Felix Steger, Balint Tamaskovics, Anett Schmiedeknecht, Andreas Dietz

Summary: Most patients with head and neck squamous cell carcinoma (HNSCC) are diagnosed with locally advanced disease and can be treated with surgery and adjuvant radio(chemo)therapy or definitive chemoradiation. However, recurrence is common, especially in high-risk cases. The ADRISK trial aims to investigate whether the addition of pembrolizumab to the standard treatment improves event-free survival in locally advanced HNSCC patients. This ongoing prospective, randomized controlled trial is recruiting patients since August 2018.

FRONTIERS IN ONCOLOGY (2023)

Article Dentistry, Oral Surgery & Medicine

The present and the future of benzydamine: expert opinion paper

Paolo Bossi, Cristina Gurizzan, Orlando Guntinas-Lichius, Razvan Hainarosie, Davide Lancini

Summary: This expert opinion narrative review summarized the current indicated applications of benzydamine and proposed new areas for exploration.

FRONTIERS IN ORAL HEALTH (2023)

Article Otorhinolaryngology

Surgery for patients with facial palsy in Germany: a diagnosis-related-groups-based nationwide analysis, 2005-2019

Susanna Seeberger, Peter Schlattmann, Orlando Guntinas-Lichius

Summary: This study analyzed the development of facial surgery in Germany and found a significant increase in the number and proportion of patients undergoing surgery for chronic flaccid paralysis of the facial nerve in the past decade. Nerve reconstruction surgery and static sling surgery showed the highest increase in surgery rate.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2023)

Article Otorhinolaryngology

N-Acetylcysteine combined with prednisolone treatment shows better hearing outcome than treatment with prednisolone alone for patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study

Mussab Kouka, Nils Bevern, Julia Bitter, Orlando Guntinas-Lichius

Summary: This retrospective study investigates the impact of adding N-acetylcysteine (NAC) to prednisolone treatment on patients with idiopathic sudden sensorineural hearing loss (ISSHL). The results suggest that combined treatment with prednisolone and NAC leads to better hearing recovery outcomes compared to prednisolone treatment alone.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2023)

Article Immunology

Age-related changes of the innate immune system of the palatine tonsil in a healthy cohort

Nico Andreas, Katharina Geissler, Juliane Priese, Orlando Guntinas-Lichius, Thomas Kamradt

Summary: Although the role of palatine tonsils in immune protection or tolerance is still debated, their removal has consequences for the immune system. The study found that all granulocyte subsets accumulate in aging tonsils, with basophils and mast cells showing the most pronounced accumulation. The immune-regulatory phenotype of tonsilar monocytes may counteract the phenomenon of inflammaging at higher age.

FRONTIERS IN IMMUNOLOGY (2023)

Review Oncology

Lymph Node Metastases from Non-Melanoma Skin Cancer of the Head and Neck

Francisco Civantos, Zachary M. Helmen, Patrick J. Bradley, Andres Coca-Pelaz, Remco De Bree, Orlando Guntinas-Lichius, Luiz P. Kowalski, Fernando Lopez, Antti A. Makitie, Alessandra Rinaldo, K. Thomas Robbins, Juan P. Rodrigo, Robert P. Takes, Alfio Ferlito

Summary: Skin cancer, especially non-melanoma skin cancer, is the most common malignancy worldwide. The management of different types of skin cancer is not clearly defined in scientific literature. Some require surgical removal, but the management of regional metastasis may vary, and microscopic metastases may be undetectable. This article summarizes the current literature on managing non-melanoma skin cancer that has spread to regional lymph nodes.

CANCERS (2023)

Article Oncology

Impact of Human Papillomavirus-Negative Dominance in Oropharyngeal Cancer on Overall Survival: A Population-Based Analysis in Germany from 2018 to 2020

Mussab Kouka, Laura Gerlach, Jens Buentzel, Holger Kaftan, Daniel Boeger, Andreas H. Mueller, Thomas Ernst, Orlando Guntinas-Lichius

Summary: The impact of HPV infection and smoking status on overall survival of OPSCC patients was investigated. HPV-positive patients had better survival, while smoking status had no independent influence on the risk of death. The majority of OPSCC cases in Thuringia were HPV-negative smokers. Optimizing therapeutic strategies for HPV-negative patients is more important.

CANCERS (2023)

No Data Available